{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:47:08Z","timestamp":1791906428006,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14008-9","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:34:33Z","timestamp":1784165673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associated characteristics of multidrug-resistant tuberculosis (MDR-TB) cases in Sub-Saharan Africa: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Martin Zang","family":"Pam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Odoom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Twum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Manu-Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wisdom K.","family":"Ahiabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"14008_CR1","doi-asserted-by":"publisher","unstructured":"Li S, Mensah E, Liu M, Pan L, Lu W, Zhou S, et al. The burden of tuberculosis and drug resistance in 22 sub-Saharan African countries, 1990\u20132021: a GBD 2021 analysis and progress towards WHO 2035 targets with projections to 2050. Front Microbiol [Internet]. 2025;16. Available from: https:\/\/doi.org\/10.3389\/fmicb.2025.1695592.","DOI":"10.3389\/fmicb.2025.1695592"},{"key":"14008_CR2","unstructured":"World Health Organization. Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. [Internet]. 2010. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/8e85f453-7ec4-429a-bfec-43487b18fbb0\/content. [2025 Dec 29]."},{"issue":"6","key":"14008_CR3","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1080\/07362994.2024.2413632","volume":"42","author":"S Nivetha","year":"2024","unstructured":"Nivetha S, Das P, Ghosh M. A comparison of stochastic and deterministic dynamics of tuberculosis model. Stochastic Anal Appl. 2024, Nov, 1;42(6):1085\u2013109. Available from: https:\/\/doi.org\/10.1080\/07362994.2024.2413632.","journal-title":"Stochastic Anal Appl"},{"issue":"198","key":"14008_CR4","doi-asserted-by":"publisher","first-page":"111225","DOI":"10.1016\/j.compbiomed.2025.111225","volume":"198","author":"A Ghosh","year":"2025","unstructured":"Ghosh A, Das P, Das SK, Das P, Upadhyay RK. Forecasting tuberculosis through mechanistic learning of transmission dynamics: insights from a case study in India. Comput Biol Med. 2025, Nov;198(198):111225. Available from: https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111225.","journal-title":"Comput Biol Med"},{"key":"14008_CR5","doi-asserted-by":"publisher","unstructured":"Musa BM, Adamu AL, Galadanci NA, Zubayr B, Odoh CN, Aliyu MH. Trends in prevalence of multi drug resistant tuberculosis in sub-saharan Africa: a systematic review and meta-analysis. PLoS One [Internet]. 2017;12(9):e0185105. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0185105.","DOI":"10.1371\/journal.pone.0185105"},{"key":"14008_CR6","doi-asserted-by":"publisher","unstructured":"Lukoye D, Ssengooba W, Musisi K, Kasule GW, Cobelens FGJ, Joloba M, et al. Variation and risk factors of drug resistant tuberculosis in sub-saharan Africa: a systematic review and meta-analysis. BMC Public Health [Internet]. 2015;15(1). Available from: https:\/\/doi.org\/10.1186\/s12889-015-1614-8.","DOI":"10.1186\/s12889-015-1614-8"},{"key":"14008_CR7","doi-asserted-by":"publisher","first-page":"107777","DOI":"10.1016\/j.ijid.2025.107777","volume":"153","author":"AM Liyew","year":"2025","unstructured":"Liyew AM, Clements ACA, Wagnew F, Gilmour B, Alene KA. Geospatial mapping of drug-resistant tuberculosis prevalence in Africa at national and sub-national levels. Int J Infect Dis [Internet]. 2025;153:107777. Available from: https:\/\/doi.org\/10.1016\/j.ijid.2025.107777.","journal-title":"Int J Infect Dis"},{"key":"14008_CR8","doi-asserted-by":"publisher","unstructured":"Lv H, Zhang X, Zhang X, Bai J, You S, Li X, et al. Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019. BMC Infect Dis [Internet]. 2024;24(1). Available from: https:\/\/doi.org\/10.1186\/s12879-024-09079-5.","DOI":"10.1186\/s12879-024-09079-5"},{"key":"14008_CR9","doi-asserted-by":"publisher","unstructured":"Molla KA, Reta MA, Ayene YY. Prevalence of multidrug-resistant tuberculosis in East Africa: a systematic review and meta-analysis. PLoS One [Internet]. 2022;17(6):e0270272. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0270272.","DOI":"10.1371\/journal.pone.0270272"},{"key":"14008_CR10","doi-asserted-by":"publisher","unstructured":"Girum T, Muktar E, Lentiro K, Wondiye H, Shewangizaw M. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines [Internet]. 2018;4(1). Available from: https:\/\/doi.org\/10.1186\/s40794-018-0065-5.","DOI":"10.1186\/s40794-018-0065-5"},{"key":"14008_CR11","doi-asserted-by":"publisher","unstructured":"Otu J, Gehre F, Zingue D, Kudzawu S, Forson A, Mane M, et al. Multidrug-resistant tuberculosis (MDR-TB): an emerging problem in west Africa. BMJ Glob Health [Internet]. 2017;2(Suppl 2):A32.3\u201333. Available from: https:\/\/doi.org\/10.1136\/bmjgh-2016-000260.85.","DOI":"10.1136\/bmjgh-2016-000260.85"},{"key":"14008_CR12","doi-asserted-by":"publisher","unstructured":"Chisompola NK, Streicher EM, Muchemwa CMK, Warren RM, Sampson SL. Molecular epidemiology of drug resistant mycobacterium tuberculosis in Africa: a systematic review. BMC Infect Dis [Internet]. 2020;20(1). Available from: https:\/\/doi.org\/10.1186\/s12879-020-05031-5.","DOI":"10.1186\/s12879-020-05031-5"},{"issue":"3","key":"14008_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/nejmoa1604544","volume":"376","author":"NS Shah","year":"2017","unstructured":"Shah NS, Auld SC, Brust JCM, Mathema B, Ismail N, Moodley P, et al. Transmission of extensively Drug-resistant tuberculosis in South Africa. N Engl J Med [Internet]. 2017;376(3):243\u201353. Available from: https:\/\/doi.org\/10.1056\/nejmoa1604544.","journal-title":"N Engl J Med"},{"issue":"3","key":"14008_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/mcp.0000000000001070","volume":"30","author":"PS Nyasulu","year":"2024","unstructured":"Nyasulu PS, Doumbia CO, Ngah V, Togo ACG, Diarra B, Chongwe G. Multidrug-resistant tuberculosis: latest opinions on epidemiology, rapid diagnosis and management. Curr Opin Pulm Med [Internet]. 2024;30(3):217\u201328. Available from: https:\/\/doi.org\/10.1097\/mcp.0000000000001070.","journal-title":"Curr Opin Pulm Med"},{"key":"14008_CR15","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021;71. Available from: https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"14008_CR16","unstructured":"Wells G, Wells G, Shea B, Shea B, O\u2019Connell D, Peterson J, et al. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014."},{"key":"14008_CR17","doi-asserted-by":"publisher","unstructured":"Admassu F, Abera E, Gizachew A, Sedoro T, Gari T. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study. BMJ Open [Internet]. 2023;13(1):e061836. Available from: https:\/\/doi.org\/10.1136\/bmjopen-2022-061836.","DOI":"10.1136\/bmjopen-2022-061836"},{"issue":"2","key":"14008_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5897\/ijmms2020.1415","volume":"12","author":"M John","year":"2020","unstructured":"John M, Hadija S, Oliva M, Balthazar N, Jaffu C. Demographic and clinical determinants of multi drug resistant tuberculosis among HIV infected patients in Tanzania. Int J Med Med Sci [Internet]. 2020;12(2):23\u201332. Available from: https:\/\/doi.org\/10.5897\/ijmms2020.1415.","journal-title":"Int J Med Med Sci"},{"key":"14008_CR19","doi-asserted-by":"publisher","unstructured":"Afful P, Vechey GA, Leta PK, Gbafu FB, Aku FY. Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: a case-control study. PLoS One [Internet]. 2023;18(11):e0294928. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0294928.","DOI":"10.1371\/journal.pone.0294928"},{"issue":"4","key":"14008_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.4103\/ijmy.ijmy_136_22","volume":"11","author":"DI Cecile","year":"2022","unstructured":"Cecile DI, Alex NN, Jo\u00eblle ND, Cedric NS, Noemy CT, Irene WG, et al. Risk factors associated to multidrug-resistant tuberculosis in patients attending the Deido District Hospital of Douala \u2013 Cameroon. Int J Mycobacteriol [Internet]. 2022;11(4):356\u201363. Available from: https:\/\/doi.org\/10.4103\/ijmy.ijmy_136_22.","journal-title":"Int J Mycobacteriol"},{"key":"14008_CR21","doi-asserted-by":"publisher","unstructured":"Demile B, Zenebu A, Shewaye H, Xia S, Guadie A. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia. BMC Infect Dis [Internet]. 2018;18(1). Available from: https:\/\/doi.org\/10.1186\/s12879-018-3167-9.","DOI":"10.1186\/s12879-018-3167-9"},{"key":"14008_CR22","doi-asserted-by":"publisher","unstructured":"Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health [Internet]. 2018;18(1). Available from: https:\/\/doi.org\/10.1186\/s12889-018-5371-3.","DOI":"10.1186\/s12889-018-5371-3"},{"key":"14008_CR23","doi-asserted-by":"publisher","unstructured":"Elduma AH, Mansournia MA, Foroushani AR, Ali HMH, Elegail AMAS, Elsony A, et al. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study. Epidemiol Health [Internet]. 2019;41:e2019014. Available from: https:\/\/doi.org\/10.4178\/epih.e2019014.","DOI":"10.4178\/epih.e2019014"},{"key":"14008_CR24","doi-asserted-by":"publisher","unstructured":"Ambaye GY, Tsegaye GW. Factors associated with multi-drug resistant tuberculosis among TB patients in selected treatment centers of amhara region: a case-control study. Ethiop J Health Sci [Internet]. 2021;31(1). Available from: https:\/\/doi.org\/10.4314\/ejhs.v31i1.4.","DOI":"10.4314\/ejhs.v31i1.4"},{"key":"14008_CR25","doi-asserted-by":"publisher","unstructured":"Gobena D, Ameya G, Haile K, Abreha G, Worku Y, Debela T. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study. Ann Clin Microbiol Antimicrob [Internet]. 2018;17(1). Available from: https:\/\/doi.org\/10.1186\/s12941-018-0283-8.","DOI":"10.1186\/s12941-018-0283-8"},{"key":"14008_CR26","doi-asserted-by":"publisher","unstructured":"Iradukunda A, Ndayishimiye GP, Sinarinzi D, Odjidja EN, Ntakaburimvo N, Nshimirimana I, et al. Key factors influencing multidrug-resistant tuberculosis in patients under anti-tuberculosis treatment in two centres in Burundi: a mixed effect modelling study. BMC Public Health [Internet]. 2021;21(1). Available from: https:\/\/doi.org\/10.1186\/s12889-021-12233-2.","DOI":"10.1186\/s12889-021-12233-2"},{"key":"14008_CR27","doi-asserted-by":"publisher","unstructured":"Mesfin EA, Beyene D, Tesfaye A, Admasu A, Addise D, Amare M, et al. Drug-resistance patterns of mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS One [Internet]. 2018;13(6):e0197737. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0197737.","DOI":"10.1371\/journal.pone.0197737"},{"issue":"2","key":"14008_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4314\/ahs.v15i2.9","volume":"15","author":"W Mulu","year":"2015","unstructured":"Mulu W, Mekkonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in amhara national regional state. Afr H Sci [Internet]. 2015;15(2):368. Available from: https:\/\/doi.org\/10.4314\/ahs.v15i2.9.","journal-title":"Afr H Sci"},{"key":"14008_CR29","doi-asserted-by":"publisher","unstructured":"Ohiengbomwan OT, Oguzie J, Eromon P, Kayode AT, Afolabi TS, Komolafe IO. Gene mutation patterns of mycobacterium tuberculosis complex and associated factors among suspected multidrug-resistant tuberculosis patients in Osun State, South-West, Nigeria. Sci Afr [Internet]. 2023;22:e01968. https:\/\/doi.org\/10.1016\/j.sciaf.2023.e01968.","DOI":"10.1016\/j.sciaf.2023.e01968"},{"key":"14008_CR30","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.jctube.2024.100466","volume":"37","author":"A Okumu","year":"2024","unstructured":"Okumu A, Orwa J, Sitati R, Omondi I, Odhiambo B, Ogoro J, et al. Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya. J Clin Tuberc Other Mycobact Dis [Internet]. 2024;37:100466. Available from: https:\/\/doi.org\/10.1016\/j.jctube.2024.100466.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"14008_CR31","doi-asserted-by":"publisher","unstructured":"Omona K, Mucha Opiyo A. Assessment of risk factors associated with multi-drug resistant tuberculosis (MDR-TB) in Gulu regional referral hospital. Afr H Sci [Internet]. 2023;23(3). Available from: https:\/\/doi.org\/10.4314\/ahs.v23i3.41.","DOI":"10.4314\/ahs.v23i3.41"},{"key":"14008_CR32","doi-asserted-by":"publisher","unstructured":"Panford V, Kumah E, Kokuro C, Adoma PO, Baidoo MA, Fusheini A, et al. Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti region, Ghana: a retrospective, cross-sectional study. BMJ Open [Internet]. 2022;12(7):e062857. Available from: Available from: https:\/\/doi.org\/10.1136\/bmjopen-2022-062857.","DOI":"10.1136\/bmjopen-2022-062857"},{"key":"14008_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/idr.s126274","volume":"10","author":"A Workicho","year":"2017","unstructured":"Workicho A, Kassahun W, Alemseged F. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. IDR [Internet]. 2017;10:91\u201396. Available from: https:\/\/doi.org\/10.2147\/idr.s126274.","journal-title":"IDR"},{"key":"14008_CR34","doi-asserted-by":"publisher","unstructured":"Ricks PM, Mavhunga F, Modi S, Indongo R, Zezai A, Lambert LA, et al. Characteristics of multidrug-resistant tuberculosis in Namibia. BMC Infect Dis [Internet]. 2012;12(1). Available from: https:\/\/doi.org\/10.1186\/1471-2334-12-385.","DOI":"10.1186\/1471-2334-12-385"},{"issue":"8","key":"14008_CR35","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.4103\/njcp.njcp_192_19","volume":"23","author":"IIE Ahiarakwem","year":"2020","unstructured":"Ahiarakwem IIE, Ekejindu IM, Akujobi CN, Aghanya IN. Multidrug-resistant tuberculosis in Imo State, southeast, Nigeria. Niger J Clin Pract [Internet]. 2020;23(8):1172\u201377. Available from: https:\/\/doi.org\/10.4103\/njcp.njcp_192_19.","journal-title":"Niger J Clin Pract"},{"key":"14008_CR36","doi-asserted-by":"publisher","unstructured":"Lema NA, Mbelele PM, Majigo M, Abade A, Matee MI. Risk factors associated with multidrug resistant tuberculosis among patients referred to Kibong\u2019oto infectious disease hospital in northern Tanzania. Tanzania J Hlth Res [Internet]. 2016;18(4). Available from: https:\/\/doi.org\/10.4314\/thrb.v18i4.2.","DOI":"10.4314\/thrb.v18i4.2"},{"key":"14008_CR37","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.12688\/f1000research.53822.2","volume":"10","author":"C Akwaowo","year":"2024","unstructured":"Akwaowo C, Umoh V, Umoh I, Usoroh E, Motilewa O, Ekpin V, et al. Effectiveness of providing cash incentives and training to community health workers on active case finding for tuberculosis in Nigeria: a cluster-randomized control trial. F1000Res [Internet]. 2024;10:1154. Available from: https:\/\/doi.org\/10.12688\/f1000research.53822.2.","journal-title":"F1000Res"},{"key":"14008_CR38","unstructured":"Mengistu M, Negash BT, Ali MM. Prevalence and associated factors of multidrug-resistant tuberculosis among tuberculosis patients at Yirgalem general hospital, Sidama regional State, Ethiopia: a cross-sectional study based on five years of secondary data. Ethiop J Health Dev. 2024;38(2)."},{"issue":"4","key":"14008_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4314\/rejhs.v8i4.2","volume":"8","author":"CA Akinleye","year":"2020","unstructured":"Akinleye CA, Onabule A, Oyekale AO, Akindele MO, Babalola OJ, Olarewaju SO. Risk factors associated with MDR-TB among tuberculosis patients in Ibadan, Oyo state, Nigeria. REJHS [Internet]. 2020;8(4):235\u201342. Available from: https:\/\/doi.org\/10.4314\/rejhs.v8i4.2.","journal-title":"REJHS"},{"key":"14008_CR40","doi-asserted-by":"publisher","unstructured":"Lasebikan VO, Ige OM. Alcohol use disorders in multidrug resistant tuberculosis MDR-TB patients and their non-tuberculosis family contacts in Nigeria. Pan Afr Med J [Internet]. 2020;36. Available from: https:\/\/doi.org\/10.11604\/pamj.2020.36.321.17118.","DOI":"10.11604\/pamj.2020.36.321.17118"},{"issue":"1","key":"14008_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.24248\/eahrj.v1i1.385","volume":"1","author":"A Liyoyo","year":"2017","unstructured":"Liyoyo A, Heysell S, Kisonga R, Lyimo J, Mleoh L, Mutayoba B, et al. Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis (MDR-TB) in Tanzania: illuminating potential factors for possible intervention. EAHRJ. 2017;1(1):31\u201339. Available from: https:\/\/doi.org\/10.24248\/eahrj.v1i1.385.","journal-title":"EAHRJ"},{"issue":"6","key":"14008_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.5588\/ijtld.14.0879","volume":"19","author":"BK Moore","year":"2015","unstructured":"Moore BK, Anyalechi E, van der Walt M, Smith S, Erasmus L, Lancaster J, et al. Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005\u20132010. Int J Tuberc Lung Dis [Internet]. 2015;19(6):663\u201369. Available from: https:\/\/doi.org\/10.5588\/ijtld.14.0879.","journal-title":"Int J Tuberc Lung Dis"},{"key":"14008_CR43","doi-asserted-by":"publisher","unstructured":"Bonsa Z, Tadesse M, Bekele E, Abeba G, Solomon E, Husen M, et al. Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in southwestern Oromia, Ethiopia: ten-year retrospective analysis. BMC Infect Dis [Internet]. 2024;24(1). Available from: https:\/\/doi.org\/10.1186\/s12879-024-10205-6.","DOI":"10.1186\/s12879-024-10205-6"},{"key":"14008_CR44","doi-asserted-by":"publisher","unstructured":"Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis [Internet]. 2015;15(1). Available from: https:\/\/doi.org\/10.1186\/s12879-015-1202-7.","DOI":"10.1186\/s12879-015-1202-7"},{"key":"14008_CR45","doi-asserted-by":"publisher","unstructured":"Bade AB, Mega TA. Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: multicenter observational study. PLoS One [Internet]. 2020;15(11):e0241684. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0241684.","DOI":"10.1371\/journal.pone.0241684"},{"issue":"6","key":"14008_CR46","doi-asserted-by":"publisher","first-page":"805","DOI":"10.5588\/ijtld.11.0522","volume":"16","author":"B Tessema","year":"2012","unstructured":"Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis [Internet]. 2012;16(6):805\u201311. Available from: https:\/\/doi.org\/10.5588\/ijtld.11.0522.","journal-title":"Int J Tuberc Lung Dis"},{"key":"14008_CR47","doi-asserted-by":"publisher","unstructured":"Verdecchia M, Keus K, Blankley S, Vambe D, Ssonko C, Piening T, et al. Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011\u20132013. PLoS One [Internet]. 2018;13(10):e0205601. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0205601.","DOI":"10.1371\/journal.pone.0205601"},{"issue":"3","key":"14008_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.5588\/ijtld.12.0100","volume":"17","author":"J Hafkin","year":"2013","unstructured":"Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, et al. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana. Int J Tuberc Lung Dis [Internet]. 2013;17(3):348\u201353. Available from: https:\/\/doi.org\/10.5588\/ijtld.12.0100.","journal-title":"Int J Tuberc Lung Dis"},{"key":"14008_CR49","unstructured":"Tud\u00f3 G, Gonz\u00e1lez J, Obama R, Rodr\u00edguez JM, Franco JR, Espasa M, et al. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int J Tuberc Lung Disease. 2004;8(1)."},{"issue":"9","key":"14008_CR50","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jiph.2023.06.007","volume":"16","author":"J de Dieu Longo","year":"2023","unstructured":"de Dieu Longo J, Woromogo SH, Tekpa G, Diemer HSC, Gando H, Djid\u00e9r\u00e9 FA, et al. Risk factors for multidrug-resistant tuberculosis in the central African republic: a case-control study. J Infect Public Health [Internet]. 2023;16(9):1341\u201345. Available from: https:\/\/doi.org\/10.1016\/j.jiph.2023.06.007.","journal-title":"J Infect Public Health"},{"issue":"3","key":"14008_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/antibiotics8030090","volume":"8","author":"MH Ali","year":"2019","unstructured":"Ali MH, Alrasheedy AA, Hassali MA, Kibuule D, Godman B. Predictors of multidrug-resistant tuberculosis (MDR-TB) in Sudan. Antibiotics [Internet]. 2019;8(3):90. Available from: https:\/\/doi.org\/10.3390\/antibiotics8030090.","journal-title":"Antibiotics"},{"key":"14008_CR52","doi-asserted-by":"publisher","unstructured":"Okethwangu D, Birungi D, Biribawa C, Kwesiga B, Turyahabwe S, Ario AR, et al. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013\u20132017. BMC Infect Dis [Internet]. 2019;19(1). Available from: https:\/\/doi.org\/10.1186\/s12879-019-4014-3.","DOI":"10.1186\/s12879-019-4014-3"},{"key":"14008_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijid.2015.08.013","volume":"39","author":"G Mulisa","year":"2015","unstructured":"Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant mycobacterium tuberculosis and associated risk factors in Oromia region of Ethiopia. Int J Infect Dis [Internet]. 2015;39:57\u201361. Available from: https:\/\/doi.org\/10.1016\/j.ijid.2015.08.013.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"14008_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s15010-022-01941-5","volume":"51","author":"J Abdul","year":"2023","unstructured":"Abdul J, Adegbite BR, Ndanga MED, Edoa JR, Mevyann RC, Mfoumbi GRAI, et al. Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central Africa. Infection [Internet]. 2023;51(3):697\u2013704. Available from: https:\/\/doi.org\/10.1007\/s15010-022-01941-5.","journal-title":"Infection"},{"key":"14008_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/20499361251339576","volume":"12","author":"BW Bwire","year":"2025","unstructured":"Bwire BW, Mbago MCY, Msengwa AS. Spatiotemporal analysis of tuberculosis drug resistance and associated risk factors in Tanzania. Ther Adv Infect [Internet]. 2025;12:12. Available from: https:\/\/doi.org\/10.1177\/20499361251339576.","journal-title":"Ther Adv Infect"},{"key":"14008_CR56","doi-asserted-by":"publisher","unstructured":"Goshiye SM, Dube L, Mogas SB, Marine BT. Predictive factors associated with multidrug-resistant tuberculosis among tuberculosis patients in Southwest Ethiopia: an unmatched case-control study. Health Sci Rep [Internet]. 2025;8(11). Available from: https:\/\/doi.org\/10.1002\/hsr2.71408.","DOI":"10.1002\/hsr2.71408"},{"issue":"12","key":"14008_CR57","doi-asserted-by":"publisher","first-page":"100409","DOI":"10.1016\/j.ijregi.2024.100409","volume":"12","author":"J Izudi","year":"2024","unstructured":"Izudi J, Engoru S, Bajunirwe F. Malnutrition is a risk factor for tuberculosis disease among household contacts: a case-control study in Uganda. IJID Regions [Internet]. 2024, Sep;12(12):100409. https:\/\/doi.org\/10.1016\/j.ijregi.2024.100409.","journal-title":"IJID Regions [Internet]"},{"issue":"3","key":"14008_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cmi.2016.08.024","volume":"23","author":"GJ Fox","year":"2017","unstructured":"Fox GJ, Schaaf HS, Mandalakas A, Chiappini E, Zumla A, Marais BJ. Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases. Clin Microbiol Infect. 2017, Mar, 1;23(3):147\u201353. [Internet]. https:\/\/doi.org\/10.1016\/j.cmi.2016.08.024.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"14008_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","volume":"10","author":"K Dheda","year":"2024","unstructured":"Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, et al. Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024, Mar, 24;10(1):22. https:\/\/doi.org\/10.1038\/s41572-024-00504-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"14008_CR60","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1186\/s12879-019-4502-5","volume":"19","author":"P MacPherson","year":"2019","unstructured":"MacPherson P, Webb EL, Variava E, Lala SG, Milovanovic M, Ratsela A, et al. Intensified household contact tracing, prevention and treatment support versus enhanced standard of care for contacts of tuberculosis cases in South Africa: study protocol for a household cluster-randomised trial. BMC Infect Dis. 2019, Oct, 12;19(1):839. https:\/\/doi.org\/10.1186\/s12879-019-4502-5.","journal-title":"BMC Infect Dis"},{"key":"14008_CR61","doi-asserted-by":"publisher","unstructured":"Seid G, Alemu A, Diriba G, Hailu M, Wondimu A, Tadesse M, et al. Active tuberculosis in household contacts of bacteriologically confirmed pulmonary tuberculosis patients: a multicenter study finding the \u2018missed one\u2019in central Ethiopia. PLoS One. 2025, Feb, 18;20(2):e0316903. https:\/\/doi.org\/10.1371\/journal.pone.0316903.","DOI":"10.1371\/journal.pone.0316903"},{"issue":"1","key":"14008_CR62","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s13063-018-3070-0","volume":"19","author":"JA Seddon","year":"2018","unstructured":"Seddon JA, Garcia-Prats AJ, Purchase SE, Osman M, Demers AM, Hoddinott G, et al. Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). Trials. 2018, Dec, 20;19(1):693. https:\/\/doi.org\/10.1186\/s13063-018-3070-0.","journal-title":"Trials"},{"issue":"24","key":"14008_CR63","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1056\/nejmoa2314318","volume":"391","author":"AC Hesseling","year":"2024","unstructured":"Hesseling AC, Purchase SE, Martinson NA, Fairlie L, Schaaf HS, Brigden J, et al. Levofloxacin preventive treatment in children exposed to MDR tuberculosis. N Engl J Med. 2024, Dec, 19;391(24):2315\u201326. https:\/\/doi.org\/10.1056\/nejmoa2314318.","journal-title":"N Engl J Med"},{"issue":"6","key":"14008_CR64","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/cid\/ciaf426","volume":"81","author":"GJ Churchyard","year":"2026","unstructured":"Churchyard GJ, Swindells S, Gupta A, Shah NS, Hughes M, Kim S, et al. Preventing Multidrug-resistant tuberculosis: the dawn of a new era. Clin Infect Dis. 2026, Dec, 15;81(6):1135\u201340. https:\/\/doi.org\/10.1093\/cid\/ciaf426.","journal-title":"Clin Infect Dis"},{"key":"14008_CR65","doi-asserted-by":"publisher","unstructured":"LeGrand KE, Edwards A, Mohlamonyane M, Dayi N, Olivier S, Gareta D, et al. Within-country heterogeneity in patterns of social contact relevant for tuberculosis infection transmission, prevention, and care. PLoS Glob Public Health. 2025, Jul, 15;5(7):e0004257. https:\/\/doi.org\/10.1371\/journal.pgph.0004257.","DOI":"10.1371\/journal.pgph.0004257"},{"key":"14008_CR66","unstructured":"Farra A, Jolly B, Ngaya G, Gando H, D\u00e9sir\u00e9 Komamgoya-Nzonzon A, Manirakiza A. Primary and secondary resistance to first-line anti-tuberculosis medications at the institute Pasteur Bangui, Central African Republic. Academic Journals Org. 2021;20(3)."},{"key":"14008_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.11604\/pamj.2016.23.157.6137","volume":"23","author":"A Misombo-Kalabela","year":"2016","unstructured":"Misombo-Kalabela A, Nguefack-Tsague G, Mireille GC, Ze EA, Diangs K, Panda T, et al. Facteurs de risque de la tuberculose multi-r\u00e9sistante dans la ville de Kinshasa en R\u00e9publique D\u00e9mocratique du Congo. Pan Afr Med J [Internet]. 2016;23:23. Available from: https:\/\/doi.org\/10.11604\/pamj.2016.23.157.6137.","journal-title":"Pan Afr Med J"},{"issue":"1","key":"14008_CR68","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1186\/s12913-023-10120-7","volume":"23","author":"R Makabayi-Mugabe","year":"2023","unstructured":"Makabayi-Mugabe R, Musaazi J, Zawedde-Muyanja S, Kizito E, Fatta K, Namwanje-Kaweesi H, et al. Community-based directly observed therapy is effective and results in better treatment outcomes for patients with multi-drug resistant tuberculosis in Uganda. BMC Health Serv Res. 2023, Nov, 13;23(1):1248. https:\/\/doi.org\/10.1186\/s12913-023-10120-7.","journal-title":"BMC Health Serv Res"},{"issue":"34","key":"14008_CR69","doi-asserted-by":"publisher","first-page":"102231","DOI":"10.1016\/j.pmedr.2023.102231","volume":"34","author":"D Amare","year":"2023","unstructured":"Amare D, Addis Alene K, Ambaw F. Acceptability of integrating traditional tuberculosis care with modern healthcare services in the amhara regional state of Northwest Ethiopia: a qualitative study. Preventative Med Rep. 2023, May;34(34):102231. https:\/\/doi.org\/10.1016\/j.pmedr.2023.102231.","journal-title":"Preventative Med Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14008-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14008-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14008-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:07:17Z","timestamp":1791904037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14008-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14008"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14008-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study did not require ethical approval or participant consent as it utilized secondary data drawn from the public domain. The study protocol was registered with PROSPERO systematic review and meta-analysis database (ID No: CRD420251185459).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1798"}}